Materials engineers at Stanford University have developed a novel hydrogel drug delivery system that transforms daily or weekly injections of diabetes and weight control drugs like Ozempic, Mounjaro, Trulicity, Victoza, and others to just once every four months.
Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives – Biotech Investments
Evolva Holding SA / Key word(s): Agreement 26-Jun-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is
June 27, 2023